Atara Biotherapeutics, Inc.: Form 8-K, filed Nov 1, 2023
Filed with the SEC on Nov 1, 2023 and accepted by EDGAR at Nov 1, 2023, 08:35 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.02 Results of operations
- Item 2.05 Exit or disposal costs
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-057146. Last ingested by Listed: Nov 11, 2026, 02:48 ET. Listed shows no prices and gives no investment advice.